CryoLogyx was founded in 2021 by Dr. Tom Congdon and Professor Matt Gibson driven by their groundbreaking research in cryopreservation. CryoLogyx specializes in developing and producing high-quality, cryopreservation solutions. The cryopreserved cells are designed to cater to the critical needs of the drug discovery and cell therapy industries, which is powered by the patented formulation - Cryoshield™. Freezing and thawing processes can be particularly stressful for cells, often resulting in reduced viability and recovery due to ice crystal formation and other factors. And the repetitive tasks of cell culture, including numerous counting and handling procedures, take significant time that researchers could otherwise dedicate to more critical aspects of their research. At CryoLogyx, we are building a future where assay-ready cells are the default option in cellbiology, and research outcomes are accelerated by weeks and months using products that enable experimental reproducibility and unparalleled ease of use.